A Phase 1 Study of ProMetic Plasminogen (Human) Intravenous in Adults and Children With Plasminogen Deficiency

Clinical trial NCT02312180 · COMPLETED

Trial details

NCT number: NCT02312180
Sponsor: Prometic Biotherapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type I Plasminogen Deficiency Hypoplasminogenemia

Start date: 2014-12-01
Primary completion: 2015-12-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.